Integra Lifesciences Holdings Corp reports results for the quarter ended June 30 - Earnings Summary

Integra LifeSciences Holdings

29/07/2026 14:32

Integra Lifesciences Holdings Corp IART.OQ reported quarterly adjusted earnings of 56 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 45 cents.  The mean expectation of ten analysts for the quarter was for earnings of 48 cents per share. Wall Street expected results to range from 46 cents to 50 cents per share.
Revenue rose 0.8% to $418.76 million from a year ago; analysts expected $418.65 million. 
Integra Lifesciences Holdings Corp's reported EPS for the quarter was 6 cents​.
The company reported quarterly net income of $4.48 million.
Integra Lifesciences Holdings Corp shares had risen by 10.0% this quarter and gained 59.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 8% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy," 6 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is  "buy."
Wall Street's median 12-month price target for Integra Lifesciences Holdings Corp is $19.00, about 4% below its last closing price of $19.76
This summary was machine generated from LSEG data July 29 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.48
0.56
Beat
Mar. 31 2026 
0.40
0.54
Beat
Dec. 31 2025 
0.80
0.83
Beat
Sep. 30 2025 
0.44
0.54
Beat